Scheme
- Beamtime at the AS XAS Beamline
Investigation of the effects of thulium oxide nanoparticles and anti-cancer drugs on tumorous 9L gliosarcoma and MDCK non cancerous cells using micro-beams monitored by the x-tream dosimetry system and characterisation of DNA damage-repair with yH2AX
GrantOverview
Research Areas
Awarded By
Contributor
- Corde Tehei, Stephanie - Chief Investigator
- Lerch, Michael - Chief Investigator
- Tehei, Moeava - Chief Investigator
Sponsor Award Id
- AS173/IM/12542
Local Award Id
- 126288
Affiliation
Contributor
- Corde Tehei, Stephanie - Chief Investigator
- Lerch, Michael - Chief Investigator
- Tehei, Moeava - Chief Investigator
Other
Assigned By
- Australian Synchrotron Research Program Funding Organization
Overview
Scheme
- Beamtime at the AS XAS Beamline
Research Areas
Awarded By
Contributor
- Corde Tehei, Stephanie - Chief Investigator
- Lerch, Michael - Chief Investigator
- Tehei, Moeava - Chief Investigator
Sponsor Award Id
- AS173/IM/12542
Local Award Id
- 126288
Affiliation
Contributor
- Corde Tehei, Stephanie - Chief Investigator
- Lerch, Michael - Chief Investigator
- Tehei, Moeava - Chief Investigator
Other
Assigned By
- Australian Synchrotron Research Program Funding Organization